Navigation Links
Gastric Banding Reverses Impact of Type 2 Diabetes
Date:1/22/2008

MELBOURNE, Australia, Jan. 22 /PRNewswire/ -- A new world-first study by Monash University researchers has found gastric banding surgery has a profound impact on one of society's biggest health issues -- diabetes.

The study, published today in Journal of the American Medical Association (JAMA), found obese patients with Type 2 diabetes who underwent gastric banding were five times more likely to have their diabetes go into long term remission, compared with patients who engaged in conventional weight loss therapies, such as a controlled calorie diet and exercise.

The four-year study, which was led by Drs John Dixon and Paul O'Brien from Monash University's Centre for Obesity Research and Education (CORE), monitored 60 volunteers for two years who underwent significant weight loss of more than 10 per cent of their body weight.

Dr Dixon said of those who underwent gastric banding surgery, 73 per cent achieved remission for Type 2 diabetes, compared to just 13 percent of the people who underwent conventional therapy.

"Our study presents strong evidence that obese patients with a Body Mass Index greater than 30 with Type 2 diabetes need to lose a significant amount of weight to improve their overall health and glycemic management," Dr Dixon said.

"Our study shows that gastric banding surgery can assist those patients to achieve this -- and with sustained results.

Professor O'Brien said obesity and Type 2 diabetes were strongly linked and combine to present one of the greatest public health problems facing our community.

"We found that the amount of weight loss was a key determinant of effectiveness. Most of those losing ten per cent of their total weight had remission of the diabetes. Few who lost less did so."

Dr Dixon said the study also found patients who lost substantial weight could not only dramatically reduce their diabetes medications, but also those for controlling blood pressure and lowering blood fats.

"We found that after two years, the surgical group when compared to the conventional therapy group displayed a four times greater reduction in glycated haemoglobin, which can be an indicator of poorly controlled diabetes," Dr Dixon said.

Gastric banding is a medical procedure where a band is placed around a patient's stomach to reduce appetite and food intake. For more information on the study, visit the CORE website: http://www.core.monash.org/


'/>"/>
SOURCE Monash University
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
2. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
3. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
4. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
5. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
6. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
7. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
8. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
9. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
10. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
11. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):